Dosimetric guidance on using brachytherapy (LDR or HDR) to offset a flawed permanent prostate implant

被引:0
|
作者
Zaider, M. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
关键词
D O I
10.1118/1.2760839
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To provide practical dosimetric advice on mending suboptimal permanent implants using low dose‐rate (LDR) or high dose‐rate (HDR) brachytherapy (BRT). The problem is to make the combination of the two radiation treatments (the initial, flawed one and the compensatory boost) clinically isoeffective with the planned dose. Methods: The device of isoeffective dose (IED) is the appropriate tool for this purpose as it accounts for the physical (temporal distribution of dose) and biological (radiosensitivity, repair kinetics, proliferation rate) treatment setting. Results: I give, as a function of separation time from the initial, flawed treatment, and stratified by risk group representative values for the additional dose (LDR or HDR) needed to make the combined treatment isoeffective with a prescription of 144 Gy of permanently‐implanted [formula omitted] seeds. Conclusions: While the IED concept, within the constraints stated in the presentation, is rigorously valid, its practical implementation depends importantly on the relevant radiobiological parameters, and in this respect the reader is urged to use his own critical judgment. © 2007, American Association of Physicists in Medicine. All rights reserved.
引用
收藏
页码:2442 / 2442
页数:1
相关论文
共 50 条
  • [31] Optimizing Dosimetric Indices for HDR Brachytherapy Using CVaR
    Holm, A.
    Larsson, T.
    Tedgren, A. Carlsson
    MEDICAL PHYSICS, 2013, 40 (06)
  • [32] Dosimetric benefits and preclinical performance of steerable needles in HDR prostate brachytherapy
    de Vries, M.
    Christianen, M. E. M. C.
    Luthart, L.
    de Vries, K. C.
    Kolkman-Deurloo, I. K. K.
    van den Dobbelsteen, J. J.
    MEDICAL ENGINEERING & PHYSICS, 2024, 128
  • [33] A Dosimetric Study Investigating the Impact of Catheter Displacement in HDR Prostate Brachytherapy
    Hunt, D.
    Soliman, H.
    Sankreacha, R.
    Morton, G.
    MEDICAL PHYSICS, 2008, 35 (06)
  • [34] Dosimetric evaluation of permanent prostate brachytherapy using Cs-131 sources
    Sinha, R.
    Weller, S.
    Kurtzman, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S395 - S395
  • [35] HDR prostate brachytherapy database: preliminary dosimetric and radiobiological analysis.
    Balabanova, A.
    Genova, B.
    Stavrev, P.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127
  • [36] QUANTITATIVE EVALUATION OF IMPLANT UNCERTAINTIES IN PERMANENT IMPLANT PROSTATE BRACHYTHERAPY
    Meyer, T.
    Husain, S.
    Angyalfi, S.
    Kay, I.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S224 - S224
  • [37] Feasibility of balloon rectal spacer implantation in HDR and LDR brachytherapy for prostate cancer treatment
    Charas, Tomer
    Billan, Salem
    BRACHYTHERAPY, 2025, 24 (01) : 186 - 189
  • [38] A comparison of MRI and CT based post implant dosimetric assessment of transperineal interstitial permanent prostate brachytherapy
    Prete, JJ
    Dubois, DF
    Bice, WS
    Prestidge, BR
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 345 - 345
  • [39] Dosimetric Evaluation of Stereotactic Prostate Reirradiation Using Cyberknife as An Alternative to HDR Brachytherapy for Locally Recurrent Prostate Cancer
    Zhang, X.
    Jang, S.
    Lee, S.
    Keohan, S.
    Hirsch, A.
    MEDICAL PHYSICS, 2022, 49 (06) : E430 - E431
  • [40] Dosimetric Variations in Gynecological HDR Brachytherapy Planning using a Hybrid HDR Applicator
    Su, F. C. F.
    Li, X.
    Huang, Y. J.
    Zhao, H.
    Nelson, G.
    Szegedi, M.
    Rassiah, P.
    Kunz, J.
    Stinnett, G.
    Salter, B. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E484 - E485